Bontril is an FDA approved diet drug that is commonly prescribed in the United States as a short-term treatment for obesity. It is based on the generic medication that is known as Phendimetrazine Tartrate.
Phendimetrazine tartrate is the primary active ingredient within this product. It is a sympathomimetic amine medicine, which is a group of drugs that work by stimulating the nervous system in a way that has been compared to amphetamines. These types of drug are also known as anorexigenic and anoretic medications.